06 Jun 2023
26m

How Boston Scientific's acquisition of Obsidio is shaping its interventional oncology business

Podcast cover

DeviceTalks Podcast Network

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

How Boston Scientific's acquisition of Obsidio is shaping its interventional oncology business